Biggest winner and loser of the S&P for 2016

04.01.2017 / 09:22

Rating:

It was so difficult to get on the S&P 500 (INDEX: .SPX)'s list of top 10 performers in 2016; Jim Cramer says it will be hard to have a repeat performance in 2017.

For example, the top performer of the S&P in 2016 was Nvidia (NASDAQ: NVDA), which more than doubled. The trajectory of the stock was steadily climbing higher until it suddenly skyrocketed in November to $117 from $68, before hitting $107 in the last days of the year.

Nvidia reminded Cramer of Intel (NASDAQ: INTC) or Qualcomm (NASDAQ: QCOM) in their heyday. Unfortunately, as the markets for PCs and cellphone chips matured, so did the stock.

And while Nvidia could head higher after it settles, Cramer said the numbers would need to come up substantially because of its sky high valuation.

Other winners of the S&P were Oneok (NYSE: OKE), Freeport-McMoRan (NYSE: FCX), Newmont Mining (NYSE: NEM), Applied Materials (NASDAQ: AMAT), Quanta Services (NYSE: PWR), Comerica (NYSE: CMA), Martin Marietta Materials (NYSE: MLM) and Halliburton.

The worst performer of the S&P was Endo International (NASDAQ: ENDP), down 73 percent in 2016. For Cramer, this company embodied everything that used to work before 2016, ranging from its tax-inverted headquarters in Dublin, strong generic drug profile and acquisitive management.

The federal government made it much harder for companies to execute tax arbitrage, thus Endo suffered. Endo's new management is now struggling with price pressure and its $8 billion debt load.

The second worst performer was First Solar (NASDAQ: FSLR), down 51 percent last year. Cramer thinks this one was simply a case of being in the wrong industry at the wrong time.

Other losers of the S&P were TripAdvisor (NASDAQ: TRIP), Perrigo (NYSE: PRGO), Vertex Pharmaceuticals (NASDAQ: VRTX), Mallinckrodt (NYSE: MNK), Allergan (NYSE: AGN), Regeneron (NASDAQ: REGN) and Stericycle (NASDAQ: SRCL).

Varchev Traders

Read more:

RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.

WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.

Varchev Finance

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

Biggest winner and loser of the S&P for 2016

London

Universal numbers